Supporting your Investment in China with Expanded Capacity
and Flexibility

Changing regulations have cemented China's status as the second-largest pharmaceutical market and led to increased investment from multinational sponsors throughout all phases of development.

Build your competitive advantage for global clinical trials with the integrated and collaborative team at the Shanghai R&D Center - Covance's newly-opened drug development facility in Shanghai.